Dominique Costagliola Selected Research

Mechanical Ventilators (Ventilator)

1/2022

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dominique Costagliola Research Topics

Disease

52	Acquired Immunodeficiency Syndrome (AIDS) 07/2022 - 05/2002
39	Infections 11/2023 - 05/2002
32	HIV Infections (HIV Infection) 11/2021 - 05/2003
20	Neoplasms (Cancer) 01/2022 - 09/2003
12	COVID-19 03/2024 - 12/2021
9	Disease Progression 11/2015 - 12/2002
8	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 09/2006
8	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2020 - 07/2006
6	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 08/2009
6	Hodgkin Disease (Hodgkin's Disease) 08/2023 - 10/2009
6	Lymphoma (Lymphomas) 12/2021 - 02/2009
6	Myocardial Infarction 01/2020 - 11/2003
5	Viremia 01/2020 - 11/2012
5	Opportunistic Infections (Opportunistic Infection) 01/2014 - 12/2002
4	Inflammation (Inflammations) 04/2016 - 01/2007
4	Hepatitis B 10/2014 - 01/2002
3	Lipodystrophy 01/2023 - 01/2008
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023 - 10/2014
3	Hypertension (High Blood Pressure) 01/2019 - 08/2014
3	Progressive Multifocal Leukoencephalopathy 01/2018 - 01/2011
3	Anus Neoplasms (Anal Cancer) 12/2017 - 06/2008
3	Coinfection 01/2015 - 06/2014
3	Sexually Transmitted Diseases (Sexually Transmitted Disease) 06/2014 - 06/2004
2	Weight Gain 01/2023 - 10/2020
2	Hepatitis 07/2022 - 02/2005
2	Bacterial Infections (Bacterial Infection) 01/2022 - 01/2020
2	Pneumonia (Pneumonitis) 01/2022 - 02/2013
2	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2020 - 01/2018
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 11/2017
2	AIDS Dementia Complex 01/2018 - 07/2014
2	Hepatitis C 06/2014 - 06/2005
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2013 - 01/2006
2	Metabolic Bone Diseases (Osteopenia) 09/2013 - 10/2012
2	Squamous Intraepithelial Lesions 01/2013 - 01/2006
2	Osteoporosis 10/2012 - 09/2012
2	Tuberculosis (Tuberculoses) 05/2012 - 03/2010
2	ST Elevation Myocardial Infarction 01/2012 - 02/2011
2	Hemorrhage 01/2012 - 02/2011
2	Human Influenza (Influenza) 05/2010 - 02/2008
1	Communicable Diseases (Infectious Diseases) 07/2023

Drug/Important Bio-Agent (IBA)

17	RNA (Ribonucleic Acid)IBA 01/2019 - 05/2003
11	Protease Inhibitors (Protease Inhibitor)IBA 01/2022 - 05/2002
10	Reverse Transcriptase InhibitorsIBA 01/2022 - 05/2003
9	NucleosidesIBA 01/2022 - 05/2003
8	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2009
7	Ritonavir (Norvir)FDA Link 01/2023 - 05/2003
7	VaccinesIBA 02/2011 - 12/2002
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2003
5	remdesivirIBA 03/2024 - 01/2022
5	Tenofovir (Viread)FDA Link 11/2023 - 01/2005
5	Antiviral Agents (Antivirals)IBA 09/2023 - 10/2007
5	Lopinavir FDA Link 01/2023 - 01/2005
5	Raltegravir Potassium FDA Link 01/2023 - 06/2014
5	EnzymesIBA 01/2023 - 10/2008
5	abacavir (Ziagen)FDA Link 01/2023 - 01/2005
5	AntibodiesIBA 03/2022 - 02/2002
4	Oxygen (Dioxygen)IBA 01/2023 - 12/2021
4	Proteins (Proteins, Gene)FDA Link 06/2021 - 12/2002
4	Atazanavir Sulfate (Reyataz)FDA Link 01/2020 - 04/2015
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 05/2011
4	Interleukin-2 (IL2)IBA 10/2010 - 01/2002
3	etravirine (TMC-125)FDA Link 10/2020 - 01/2014
3	Maraviroc FDA Link 01/2020 - 06/2014
3	efavirenz (Sustiva)FDA Link 01/2018 - 08/2012
3	Anti-Retroviral Agents (Antiretroviral Agents)IBA 02/2013 - 01/2006
2	Emtricitabine (Emtriva)FDA Link 11/2023 - 07/2022
2	RacivirIBA 11/2023 - 01/2014
2	Integrase InhibitorsIBA 11/2023 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2023 - 09/2006
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2023 - 12/2021
2	IntegrasesIBA 01/2023 - 01/2022
2	Immunoglobulin G (IgG)IBA 02/2022 - 02/2002
2	CytokinesIBA 12/2021 - 05/2010
2	A-factor (Streptomyces)IBA 11/2021 - 06/2007
2	Neutralizing AntibodiesIBA 06/2021 - 05/2010
2	InterferonsIBA 06/2021 - 01/2011
2	Darunavir (Prezista)FDA Link 01/2020 - 01/2018
2	Growth Hormone (Somatotropin)IBA 01/2020 - 01/2018
2	Rituximab (Mabthera)FDA Link 11/2017 - 09/2006
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2017 - 09/2006
2	LipidsIBA 01/2017 - 01/2010
2	Rosuvastatin Calcium (Crestor)FDA Link 04/2016 - 01/2010
2	LigandsIBA 01/2009 - 09/2006
2	Natural Cytotoxicity Triggering Receptor 2IBA 01/2009 - 09/2006
2	Zidovudine (Retrovir)FDA LinkGeneric 01/2007 - 04/2004
1	cilgavimabIBA 02/2024
1	cilgavimab and tixagevimab drug combinationIBA 02/2024
1	tixagevimabIBA 02/2024
1	baricitinibIBA 10/2023
1	Vinblastine (Vinblastine Sulfate)FDA Link 08/2023
1	Brentuximab VedotinIBA 08/2023
1	Dacarbazine (DIC)FDA LinkGeneric 08/2023
1	Interferon-gamma (Interferon, gamma)IBA 07/2023
1	Tuberculin (PPD)IBA 07/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023

Therapy/Procedure

63	Therapeutics 01/2023 - 05/2002
46	Highly Active Antiretroviral Therapy (HAART) 01/2023 - 07/2002
7	Art Therapy 08/2023 - 06/2013
3	Drug Therapy (Chemotherapy) 01/2020 - 01/2006
2	Percutaneous Coronary Intervention 01/2012 - 02/2011